Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial.
BACKGROUND: Choroideremia is an X-linked recessive disease that leads to blindness due to mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed the effects of retinal gene therapy with an adeno-associated viral (AAV) vector encoding REP1 (AAV.REP1) in patients with th...
Váldodahkkit: | Maclaren, R, Groppe, M, Barnard, A, Cottriall, C, Tolmachova, T, Seymour, L, Clark, K, During, M, Cremers, F, Black, G, Lotery, A, Downes, S, Webster, A, Seabra, M |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
2014
|
Geahča maid
-
Retinal gene therapy in patients with choroideremia: Initial fi ndings from a phase 1/2 clinical trial
Dahkki: MacLaren, R, et al.
Almmustuhtton: (2014) -
Visual acuity after retinal gene therapy for Choroideremia
Dahkki: Edwards, T, et al.
Almmustuhtton: (2016) -
Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia
Dahkki: Xue, K, et al.
Almmustuhtton: (2018) -
AAV2/2-CBA-REP1 Vector with WPRE Provides Functional Expression of the Transgene in Choroideremia Mouse Knock-Out and Patient Cells
Dahkki: Tolmachova, T, et al.
Almmustuhtton: (2012) -
Retinal pigment epithelium defects accelerate photoreceptor degeneration in cell type-specific knockout mouse models of choroideremia.
Dahkki: Tolmachova, T, et al.
Almmustuhtton: (2010)